Quince Therapeutics Stock Explodes 300% On Strategic Review

Quince Therapeutics Inc (NASDAQ:QNCX) shares are soaring Tuesday as the company has engaged LifeSci Capital to serve as its exclusive financial advisor. This strategic move has spurred the stock some 300% higher Tuesday afternoon, with volume exceeding 1.1 billion shares. Here’s what investors need to know.Quince Therapeutics stock is charging ahead with explosive momentum. What’s behind QNCX gains?Quince Explores Strategic AlternativesQuince Therapeutics announced recently that it has engaged LifeSci Capit ...